Expert Outlook: Fate Therapeutics Through The Eyes Of 9 Analysts
Across the recent three months, 9 analysts have shared their insights on Fate Therapeutics (NASDAQ:FATE), expressing a variety…
This Best Buy Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…
Alibaba To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…
Forecasting The Future: 8 Analyst Projections For Fate Therapeutics
8 analysts have expressed a variety of opinions on Fate Therapeutics (NASDAQ:FATE) over the past quarter, offering a…
Where Fate Therapeutics Stands With Analysts
6 analysts have shared their evaluations of Fate Therapeutics (NASDAQ:FATE) during the recent three months, expressing a mix…
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers Rallybio (NASDAQ:RLYB) shares rose 31.9% to $2.15 during Wednesday’s after-market session. The company’s market cap stands at…
Pinstripes, SoFi Technologies And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 60 points on Wednesday.
Shares of Pinstripes (NYSE: PNST) shares fell in pre-market trading after surging 22% on Tuesday.
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares rose 58.2% to $0.4 during Tuesday’s after-market session. The company’s market cap stands…
Analyst Ratings for Fate Therapeutics
Fate Therapeutics (NASDAQ:FATE) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Recap: Fate Therapeutics Q3 Earnings
Fate Therapeutics (NASDAQ:FATE) reported its Q3 earnings results on Wednesday, November 8, 2023 at 04:01 PM. Here’s what…